Skip to main content
UKHSA data dashboard

BetaThis is a new service - your feedback will help us to improve it.

Information
Yellow heat health alerts issued for the East Midlands, East of England, London, South East and South West

Regions affected include the East Midlands, East of England, London, South East and South West from 12pm Saturday 4 July until 5pm Wednesday 8 July. For more information, please see the Weather health alerts page.

Entry title:

Antimicrobial resistance in Klebsiella pneumoniae (K. pneumoniae) bacteraemia

Last updated on Thursday, 25 June 2026 at 04:00pm

This page provides information on resistance to antimicrobials in Klebsiella pneumoniae bacteraemia (bacteria found in blood specimens). Data breakdowns are available for England, by UKHSA Region and by Integrated Care Board.

Filter results by location
Reset

Overview

Antibiotics are grouped based on the UK-AWaRe classification. These are:

Access
Access antibiotics are with a narrow spectrum of activity, fewer side effects, lower costs, and importantly lower resistance potential. These are first or second choice antibiotics recommended for empiric treatment of the most common infections and should be widely available. That is to say, these antibiotics should offer the best therapeutic value while minimizing the potential for resistance.

Watch
Watch antibiotics have a higher resistance potential and are broader-spectrum antibiotics. These are first or second choice antibiotics indicated for a limited number of infective syndromes. As these antibiotics are considered to have a higher potential for selection of AMR, their use should be carefully monitored.

Reserve
Reserve antibiotics are “last resort” antibiotics, including new antibiotics. These are used for highly selected patients (life-threatening infections due to multi-drug-resistant bacteria) and are closely monitored and prioritized as targets of stewardship programmes to ensure continued effectiveness.

Resistance

Rolling monthly average percent of K. pneumoniae bacteraemia resistant to co-amoxiclav, ciprofloxacin, gentamicin, piperacillin with tazobactam, amikacin, carbapenems or third-generation cephalosporins. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including month of 1 Apr 2026

ChartThere are 7 plots on this chart. The horizontal X-axis is labelled 'date'. Whilst the vertical Y-axis is labelled 'metric'. This is plot number 1 on this chart. This is a dark blue solid line plot. The plot has a label of 'Amikacin (Watch)'. This plot shows data for K-pneumoniae. Specifically the metric 'k-pneumoniae_testing_bacteraemiaPercentResistantRollingMonth' for the England area, along with the age banding of 'all' for the gender group of all. This plot shows data from 01 April 2021 to 01 April 2026. It rose from 1.19 on 01 April 2021 to 2.97 on 01 February 2022. It fell from 3.37 on 01 March 2022 to 2.61 on 01 December 2022. It fell from 2.37 on 01 January 2023 to 1.97 on 01 October 2023. It rose from 1.8 on 01 November 2023 to 2.64 on 01 August 2024. It fell from 2.6 on 01 September 2024 to 2.22 on 01 June 2025. And finally. It fell from 3.01 on 01 July 2025 to 2.06 on 01 April 2026. This is plot number 2 on this chart. This is a turquoise solid line plot. The plot has a label of 'Carbapenems (Reserve)'. This plot shows data for K-pneumoniae. Specifically the metric 'k-pneumoniae_testing_bacteraemiaPercentResistantRollingMonth' for the England area, along with the age banding of 'all' for the gender group of all. This plot shows data from 01 April 2021 to 01 April 2026. It fell from 1.17 on 01 April 2021 to 1.14 on 01 February 2022. It rose from 1.01 on 01 March 2022 to 1.52 on 01 December 2022. It rose from 1.59 on 01 January 2023 to 1.76 on 01 October 2023. It fell from 1.57 on 01 November 2023 to 1.46 on 01 August 2024. It fell from 1.69 on 01 September 2024 to 1.11 on 01 June 2025. And finally. It fell from 1.34 on 01 July 2025 to 1.17 on 01 April 2026. This is plot number 3 on this chart. This is a dark pink solid line plot. The plot has a label of 'Ciprofloxacin (Watch)'. This plot shows data for K-pneumoniae. Specifically the metric 'k-pneumoniae_testing_bacteraemiaPercentResistantRollingMonth' for the England area, along with the age banding of 'all' for the gender group of all. This plot shows data from 01 April 2021 to 01 April 2026. It rose from 14.84 on 01 April 2021 to 17.14 on 01 February 2022. It fell from 17.61 on 01 March 2022 to 17.47 on 01 December 2022. It rose from 17.88 on 01 January 2023 to 18.37 on 01 October 2023. It fell from 19.3 on 01 November 2023 to 18.93 on 01 August 2024. It fell from 19.31 on 01 September 2024 to 17.94 on 01 June 2025. And finally. It fell from 18.6 on 01 July 2025 to 17.76 on 01 April 2026. This is plot number 4 on this chart. This is a orange solid line plot. The plot has a label of 'Co-amoxiclav (Watch)'. This plot shows data for K-pneumoniae. Specifically the metric 'k-pneumoniae_testing_bacteraemiaPercentResistantRollingMonth' for the England area, along with the age banding of 'all' for the gender group of all. This plot shows data from 01 April 2021 to 01 April 2026. It rose from 28.75 on 01 April 2021 to 30.33 on 01 February 2022. It rose from 30.61 on 01 March 2022 to 32.15 on 01 December 2022. It rose from 33.1 on 01 January 2023 to 34.08 on 01 October 2023. It fell from 35.84 on 01 November 2023 to 32.96 on 01 August 2024. It fell from 33.76 on 01 September 2024 to 32.15 on 01 June 2025. And finally. It rose from 32.19 on 01 July 2025 to 33.42 on 01 April 2026. This is plot number 5 on this chart. This is a dark grey solid line plot. The plot has a label of 'Gentamicin (Access)'. This plot shows data for K-pneumoniae. Specifically the metric 'k-pneumoniae_testing_bacteraemiaPercentResistantRollingMonth' for the England area, along with the age banding of 'all' for the gender group of all. This plot shows data from 01 April 2021 to 01 April 2026. It rose from 9.3 on 01 April 2021 to 10.24 on 01 February 2022. It rose from 10.19 on 01 March 2022 to 10.5 on 01 December 2022. It rose from 10.53 on 01 January 2023 to 10.72 on 01 October 2023. It rose from 11.15 on 01 November 2023 to 13.63 on 01 August 2024. It fell from 13.85 on 01 September 2024 to 9.55 on 01 June 2025. And finally. It fell from 11.37 on 01 July 2025 to 10.58 on 01 April 2026. This is plot number 6 on this chart. This is a light purple solid line plot. The plot has a label of 'Piperacillin with tazobactam (Watch)'. This plot shows data for K-pneumoniae. Specifically the metric 'k-pneumoniae_testing_bacteraemiaPercentResistantRollingMonth' for the England area, along with the age banding of 'all' for the gender group of all. This plot shows data from 01 April 2021 to 01 April 2026. It rose from 18.1 on 01 April 2021 to 18.49 on 01 February 2022. It rose from 19.16 on 01 March 2022 to 22.06 on 01 December 2022. It rose from 23.71 on 01 January 2023 to 24.61 on 01 October 2023. It fell from 26.36 on 01 November 2023 to 22.65 on 01 August 2024. It rose from 23.15 on 01 September 2024 to 23.23 on 01 June 2025. And finally. It fell from 22.67 on 01 July 2025 to 20.83 on 01 April 2026. This is plot number 7 on this chart. This is a burgundy solid line plot. The plot has a label of 'Third-generation cephalosporins (Watch)'. This plot shows data for K-pneumoniae. Specifically the metric 'k-pneumoniae_testing_bacteraemiaPercentResistantRollingMonth' for the England area, along with the age banding of 'all' for the gender group of all. This plot shows data from 01 April 2021 to 01 April 2026. It rose from 16.03 on 01 April 2021 to 16.8 on 01 February 2022. It rose from 17.37 on 01 March 2022 to 19.65 on 01 December 2022. It fell from 19.48 on 01 January 2023 to 19.06 on 01 October 2023. It rose from 20.06 on 01 November 2023 to 20.55 on 01 August 2024. It fell from 21.51 on 01 September 2024 to 17.55 on 01 June 2025. And finally. It rose from 18.41 on 01 July 2025 to 18.93 on 01 April 2026. There is no reporting delay period being tracked for the data on this chart. - Refer to tabular data.
Tabular data

Resistance data for rolling monthly average percent of K. pneumoniae bacteraemia resistant to co-amoxiclav, ciprofloxacin, gentamicin, piperacillin with tazobactam, amikacin, carbapenems or third-generation cephalosporins. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including 1 April 2026

Month Amikacin (Watch) Carbapenems (Reserve)
1 Apr 20262.061.17
1 Mar 20262.391.49
1 Feb 20262.531.49
1 Jan 20262.401.52
1 Dec 20252.741.44
1 Nov 20252.611.51
1 Oct 20252.981.61
1 Sep 20253.081.69
1 Aug 20253.241.51
1 Jul 20253.011.34
1 Jun 20252.221.11
1 May 20252.131.53
1 Apr 20252.731.78
1 Mar 20252.751.67
1 Feb 20253.071.30
1 Jan 20252.881.26
1 Dec 20243.111.65
1 Nov 20242.881.89
1 Oct 20242.711.84
1 Sep 20242.601.69
1 Aug 20242.641.46
1 Jul 20242.941.69
1 Jun 20242.951.43
1 May 20242.591.42
1 Apr 20242.621.52
1 Mar 20242.151.68
1 Feb 20242.531.68
1 Jan 20241.711.37
1 Dec 20231.901.47
1 Nov 20231.801.57
1 Oct 20231.971.76
1 Sep 20231.881.66
1 Aug 20232.171.48
1 Jul 20232.221.22
1 Jun 20232.591.36
1 May 20232.411.49
1 Apr 20232.181.64
1 Mar 20232.171.68
1 Feb 20231.771.67
1 Jan 20232.371.59
1 Dec 20222.611.52
1 Nov 20223.141.85
1 Oct 20223.011.72
1 Sep 20222.881.76
1 Aug 20222.151.62
1 Jul 20221.671.79
1 Jun 20221.981.72
1 May 20222.431.33
1 Apr 20223.311.01
1 Mar 20223.371.01
1 Feb 20222.971.14
1 Jan 20222.921.72
1 Dec 20212.441.67
1 Nov 20212.651.48
1 Oct 20212.180.99
1 Sep 20212.140.76
1 Aug 20211.700.74
1 Jul 20211.560.75
1 Jun 20211.230.80
1 May 20211.540.97
1 Apr 20211.191.17
Month Ciprofloxacin (Watch) Co-amoxiclav (Watch)
1 Apr 202617.7633.42
1 Mar 202618.3134.95
1 Feb 202618.2235.31
1 Jan 202617.1733.71
1 Dec 202518.3933.96
1 Nov 202517.6433.86
1 Oct 202518.5033.50
1 Sep 202517.9032.58
1 Aug 202519.4333.13
1 Jul 202518.6032.19
1 Jun 202517.9432.15
1 May 202516.9231.28
1 Apr 202517.5433.37
1 Mar 202517.6532.82
1 Feb 202518.6132.82
1 Jan 202519.1333.36
1 Dec 202420.1233.50
1 Nov 202420.2835.42
1 Oct 202420.1134.41
1 Sep 202419.3133.76
1 Aug 202418.9332.96
1 Jul 202418.9533.61
1 Jun 202418.5133.47
1 May 202418.6532.91
1 Apr 202417.5831.44
1 Mar 202417.6431.83
1 Feb 202417.4133.05
1 Jan 202418.2034.84
1 Dec 202318.5436.36
1 Nov 202319.3035.84
1 Oct 202318.3734.08
1 Sep 202318.0832.91
1 Aug 202317.1431.60
1 Jul 202318.9532.28
1 Jun 202319.4032.52
1 May 202319.3932.12
1 Apr 202318.1432.56
1 Mar 202317.8933.26
1 Feb 202317.1233.28
1 Jan 202317.8833.10
1 Dec 202217.4732.15
1 Nov 202217.5432.14
1 Oct 202215.9131.45
1 Sep 202215.6730.08
1 Aug 202215.2328.98
1 Jul 202215.7927.07
1 Jun 202216.7827.75
1 May 202217.6929.25
1 Apr 202218.0831.02
1 Mar 202217.6130.61
1 Feb 202217.1430.33
1 Jan 202217.4331.59
1 Dec 202117.4931.89
1 Nov 202116.9630.82
1 Oct 202116.0128.27
1 Sep 202115.3628.33
1 Aug 202115.2529.26
1 Jul 202115.1629.95
1 Jun 202115.1129.01
1 May 202115.0228.03
1 Apr 202114.8428.75
Month Gentamicin (Access) Piperacillin with tazobactam (Watch)
1 Apr 202610.5820.83
1 Mar 202610.7122.02
1 Feb 202610.1922.38
1 Jan 20269.9623.01
1 Dec 202510.3723.87
1 Nov 202510.2323.66
1 Oct 202511.2323.17
1 Sep 202511.7722.06
1 Aug 202512.2023.14
1 Jul 202511.3722.67
1 Jun 20259.5523.23
1 May 20259.6322.65
1 Apr 202511.4224.61
1 Mar 202512.4323.97
1 Feb 202512.9024.44
1 Jan 202512.0323.59
1 Dec 202412.3324.54
1 Nov 202412.6925.03
1 Oct 202413.4424.58
1 Sep 202413.8523.15
1 Aug 202413.6322.65
1 Jul 202412.3923.25
1 Jun 202411.7623.78
1 May 202410.9523.76
1 Apr 202410.5523.37
1 Mar 202410.4123.54
1 Feb 202411.6423.09
1 Jan 202411.9424.73
1 Dec 202311.9725.43
1 Nov 202311.1526.36
1 Oct 202310.7224.61
1 Sep 20239.3924.39
1 Aug 20239.3323.22
1 Jul 202310.2122.79
1 Jun 202311.4522.76
1 May 202310.9522.37
1 Apr 202310.4723.43
1 Mar 202310.2823.59
1 Feb 202310.0923.81
1 Jan 202310.5323.71
1 Dec 202210.5022.06
1 Nov 202210.7621.27
1 Oct 20229.9220.00
1 Sep 20229.4319.78
1 Aug 20229.1119.62
1 Jul 20228.3518.34
1 Jun 20228.9219.02
1 May 20229.1519.91
1 Apr 202210.4220.74
1 Mar 202210.1919.16
1 Feb 202210.2418.49
1 Jan 202210.5219.08
1 Dec 202110.4919.81
1 Nov 202110.5219.61
1 Oct 20219.5717.89
1 Sep 20219.0317.92
1 Aug 20218.4217.60
1 Jul 20218.2419.31
1 Jun 20218.2818.73
1 May 20218.6618.02
1 Apr 20219.3018.10
Month Third-generation cephalosporins (Watch)
1 Apr 202618.93
1 Mar 202619.32
1 Feb 202618.79
1 Jan 202618.27
1 Dec 202518.38
1 Nov 202518.50
1 Oct 202518.33
1 Sep 202518.23
1 Aug 202518.53
1 Jul 202518.41
1 Jun 202517.55
1 May 202518.30
1 Apr 202519.16
1 Mar 202519.02
1 Feb 202518.98
1 Jan 202519.25
1 Dec 202420.60
1 Nov 202421.31
1 Oct 202422.27
1 Sep 202421.51
1 Aug 202420.55
1 Jul 202419.35
1 Jun 202418.92
1 May 202418.57
1 Apr 202417.33
1 Mar 202416.71
1 Feb 202417.33
1 Jan 202418.46
1 Dec 202319.35
1 Nov 202320.06
1 Oct 202319.06
1 Sep 202318.88
1 Aug 202317.31
1 Jul 202318.80
1 Jun 202319.03
1 May 202319.15
1 Apr 202319.02
1 Mar 202318.75
1 Feb 202319.12
1 Jan 202319.48
1 Dec 202219.65
1 Nov 202219.10
1 Oct 202217.90
1 Sep 202216.70
1 Aug 202216.59
1 Jul 202215.80
1 Jun 202216.69
1 May 202216.72
1 Apr 202217.67
1 Mar 202217.37
1 Feb 202216.80
1 Jan 202217.86
1 Dec 202117.77
1 Nov 202118.14
1 Oct 202115.83
1 Sep 202115.54
1 Aug 202115.40
1 Jul 202115.87
1 Jun 202115.88
1 May 202115.67
1 Apr 202116.03
Download

Download data

Select format
About

Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change. Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months. Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.

Amikacin

Testing

Rolling monthly average number of K. pneumoniae bacteraemia tested for resistance to amikacin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including month of 1 Apr 2026

ChartThere is only 1 plot on this chart. The horizontal X-axis is labelled 'date'. Whilst the vertical Y-axis is labelled 'metric'. This is a dark blue solid bar plot. This plot shows data for K-pneumoniae. Specifically the metric 'k-pneumoniae_testing_bacteraemiaNumberTestedRollingMonth' for the England area, along with the age banding of 'all' for the gender group of all. This plot shows data from 01 April 2021 to 01 April 2026. It rose from 392.33 on 01 April 2021 to 404.33 on 01 February 2022. It rose from 405.33 on 01 March 2022 to 485.0 on 01 December 2022. It rose from 478.33 on 01 January 2023 to 557.33 on 01 October 2023. It fell from 556.33 on 01 November 2023 to 556.0 on 01 August 2024. It fell from 589.0 on 01 September 2024 to 481.0 on 01 June 2025. And finally. It fell from 532.0 on 01 July 2025 to 484.67 on 01 April 2026. There is no reporting delay period being tracked for the data on this chart. - Refer to tabular data.
Tabular data

Testing data for rolling monthly average number of K. pneumoniae bacteraemia tested for resistance to amikacin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including 1 April 2026

Month Number tested
1 Apr 2026484.67
1 Mar 2026489.00
1 Feb 2026514.67
1 Jan 2026555.33
1 Dec 2025584.67
1 Nov 2025600.33
1 Oct 2025614.33
1 Sep 2025617.33
1 Aug 2025577.00
1 Jul 2025532.00
1 Jun 2025481.00
1 May 2025485.00
1 Apr 2025476.00
1 Mar 2025497.33
1 Feb 2025510.00
1 Jan 2025532.00
1 Dec 2024546.00
1 Nov 2024556.33
1 Oct 2024577.33
1 Sep 2024589.00
1 Aug 2024556.00
1 Jul 2024521.67
1 Jun 2024486.00
1 May 2024501.00
1 Apr 2024483.33
1 Mar 2024480.67
1 Feb 2024474.00
1 Jan 2024506.67
1 Dec 2023544.67
1 Nov 2023556.33
1 Oct 2023557.33
1 Sep 2023533.33
1 Aug 2023521.33
1 Jul 2023495.00
1 Jun 2023475.33
1 May 2023443.33
1 Apr 2023428.00
1 Mar 2023430.33
1 Feb 2023452.00
1 Jan 2023478.33
1 Dec 2022485.00
1 Nov 2022510.33
1 Oct 2022498.67
1 Sep 2022485.33
1 Aug 2022435.00
1 Jul 2022419.33
1 Jun 2022405.00
1 May 2022412.00
1 Apr 2022402.67
1 Mar 2022405.33
1 Feb 2022404.33
1 Jan 2022445.33
1 Dec 2021477.33
1 Nov 2021491.33
1 Oct 2021458.67
1 Sep 2021436.33
1 Aug 2021411.67
1 Jul 2021406.33
1 Jun 2021380.00
1 May 2021389.33
1 Apr 2021392.33
Download

Download data

Select format
About

Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change. Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months. Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.

Testing

Rolling monthly average percent of K. pneumoniae bacteraemia tested for resistance to amikacin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including month of 1 Apr 2026

ChartThere is only 1 plot on this chart. The horizontal X-axis is labelled 'date'. Whilst the vertical Y-axis is labelled 'metric'. This is a dark blue solid line plot. This plot shows data for K-pneumoniae. Specifically the metric 'k-pneumoniae_testing_bacteraemiaPercentTestedRollingMonth' for the England area, along with the age banding of 'all' for the gender group of all. This plot shows data from 01 April 2021 to 01 April 2026. It fell from 70.76 on 01 April 2021 to 70.63 on 01 February 2022. It fell from 70.8 on 01 March 2022 to 69.78 on 01 December 2022. It fell from 69.99 on 01 January 2023 to 68.94 on 01 October 2023. It fell from 70.2 on 01 November 2023 to 69.5 on 01 August 2024. It fell from 70.54 on 01 September 2024 to 64.56 on 01 June 2025. And finally. It fell from 66.75 on 01 July 2025 to 63.27 on 01 April 2026. There is no reporting delay period being tracked for the data on this chart. - Refer to tabular data.
Tabular data

Testing data for rolling monthly average percent of K. pneumoniae bacteraemia tested for resistance to amikacin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including 1 April 2026

Month % tested
1 Apr 202663.27
1 Mar 202662.29
1 Feb 202665.31
1 Jan 202666.07
1 Dec 202567.75
1 Nov 202567.42
1 Oct 202568.68
1 Sep 202569.17
1 Aug 202568.85
1 Jul 202566.75
1 Jun 202564.56
1 May 202564.93
1 Apr 202565.84
1 Mar 202566.71
1 Feb 202566.49
1 Jan 202567.17
1 Dec 202467.32
1 Nov 202468.14
1 Oct 202468.53
1 Sep 202470.54
1 Aug 202469.50
1 Jul 202469.28
1 Jun 202467.41
1 May 202469.01
1 Apr 202468.61
1 Mar 202468.67
1 Feb 202467.81
1 Jan 202469.32
1 Dec 202370.56
1 Nov 202370.20
1 Oct 202368.94
1 Sep 202368.69
1 Aug 202369.47
1 Jul 202369.52
1 Jun 202369.55
1 May 202368.58
1 Apr 202368.48
1 Mar 202368.47
1 Feb 202369.54
1 Jan 202369.99
1 Dec 202269.78
1 Nov 202271.03
1 Oct 202269.46
1 Sep 202269.19
1 Aug 202268.50
1 Jul 202270.54
1 Jun 202270.43
1 May 202269.83
1 Apr 202270.53
1 Mar 202270.80
1 Feb 202270.63
1 Jan 202269.53
1 Dec 202170.15
1 Nov 202170.65
1 Oct 202169.29
1 Sep 202168.77
1 Aug 202167.82
1 Jul 202168.70
1 Jun 202168.47
1 May 202169.46
1 Apr 202170.76
Download

Download data

Select format
About

Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change. Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months. Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.

Resistance

Rolling monthly average percent of K. pneumoniae bacteraemia resistant to amikacin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including month of 1 Apr 2026

ChartThere is only 1 plot on this chart. The horizontal X-axis is labelled 'date'. Whilst the vertical Y-axis is labelled 'metric'. This is a dark blue solid line plot. This plot shows data for K-pneumoniae. Specifically the metric 'k-pneumoniae_testing_bacteraemiaPercentResistantRollingMonth' for the England area, along with the age banding of 'all' for the gender group of all. This plot shows data from 01 April 2021 to 01 April 2026. It rose from 1.19 on 01 April 2021 to 2.97 on 01 February 2022. It fell from 3.37 on 01 March 2022 to 2.61 on 01 December 2022. It fell from 2.37 on 01 January 2023 to 1.97 on 01 October 2023. It rose from 1.8 on 01 November 2023 to 2.64 on 01 August 2024. It fell from 2.6 on 01 September 2024 to 2.22 on 01 June 2025. And finally. It fell from 3.01 on 01 July 2025 to 2.06 on 01 April 2026. There is no reporting delay period being tracked for the data on this chart. - Refer to tabular data.
Tabular data

Resistance data for rolling monthly average percent of K. pneumoniae bacteraemia resistant to amikacin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including 1 April 2026

Month % resistant
1 Apr 20262.06
1 Mar 20262.39
1 Feb 20262.53
1 Jan 20262.40
1 Dec 20252.74
1 Nov 20252.61
1 Oct 20252.98
1 Sep 20253.08
1 Aug 20253.24
1 Jul 20253.01
1 Jun 20252.22
1 May 20252.13
1 Apr 20252.73
1 Mar 20252.75
1 Feb 20253.07
1 Jan 20252.88
1 Dec 20243.11
1 Nov 20242.88
1 Oct 20242.71
1 Sep 20242.60
1 Aug 20242.64
1 Jul 20242.94
1 Jun 20242.95
1 May 20242.59
1 Apr 20242.62
1 Mar 20242.15
1 Feb 20242.53
1 Jan 20241.71
1 Dec 20231.90
1 Nov 20231.80
1 Oct 20231.97
1 Sep 20231.88
1 Aug 20232.17
1 Jul 20232.22
1 Jun 20232.59
1 May 20232.41
1 Apr 20232.18
1 Mar 20232.17
1 Feb 20231.77
1 Jan 20232.37
1 Dec 20222.61
1 Nov 20223.14
1 Oct 20223.01
1 Sep 20222.88
1 Aug 20222.15
1 Jul 20221.67
1 Jun 20221.98
1 May 20222.43
1 Apr 20223.31
1 Mar 20223.37
1 Feb 20222.97
1 Jan 20222.92
1 Dec 20212.44
1 Nov 20212.65
1 Oct 20212.18
1 Sep 20212.14
1 Aug 20211.70
1 Jul 20211.56
1 Jun 20211.23
1 May 20211.54
1 Apr 20211.19
Download

Download data

Select format
About

Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change. Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months. Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.

Carbapenems

Testing

Rolling monthly average number of K. pneumoniae bacteraemia tested for resistance to carbapenems. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including month of 1 Apr 2026

ChartThere is only 1 plot on this chart. The horizontal X-axis is labelled 'date'. Whilst the vertical Y-axis is labelled 'metric'. This is a dark blue solid bar plot. This plot shows data for K-pneumoniae. Specifically the metric 'k-pneumoniae_testing_bacteraemiaNumberTestedRollingMonth' for the England area, along with the age banding of 'all' for the gender group of all. This plot shows data from 01 April 2021 to 01 April 2026. It rose from 542.67 on 01 April 2021 to 557.0 on 01 February 2022. It rose from 559.33 on 01 March 2022 to 681.67 on 01 December 2022. It rose from 669.0 on 01 January 2023 to 774.67 on 01 October 2023. It rose from 762.67 on 01 November 2023 to 774.0 on 01 August 2024. It fell from 807.0 on 01 September 2024 to 720.0 on 01 June 2025. And finally. It fell from 773.67 on 01 July 2025 to 738.33 on 01 April 2026. There is no reporting delay period being tracked for the data on this chart. - Refer to tabular data.
Tabular data

Testing data for rolling monthly average number of K. pneumoniae bacteraemia tested for resistance to carbapenems. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including 1 April 2026

Month Number tested
1 Apr 2026738.33
1 Mar 2026758.33
1 Feb 2026759.67
1 Jan 2026810.67
1 Dec 2025832.67
1 Nov 2025860.33
1 Oct 2025870.67
1 Sep 2025869.00
1 Aug 2025814.67
1 Jul 2025773.67
1 Jun 2025720.00
1 May 2025720.67
1 Apr 2025694.33
1 Mar 2025719.33
1 Feb 2025741.33
1 Jan 2025769.33
1 Dec 2024786.00
1 Nov 2024792.00
1 Oct 2024816.00
1 Sep 2024807.00
1 Aug 2024774.00
1 Jul 2024729.00
1 Jun 2024700.00
1 May 2024703.67
1 Apr 2024679.00
1 Mar 2024672.67
1 Feb 2024673.67
1 Jan 2024706.33
1 Dec 2023746.67
1 Nov 2023762.67
1 Oct 2023774.67
1 Sep 2023744.33
1 Aug 2023720.33
1 Jul 2023685.00
1 Jun 2023660.00
1 May 2023626.33
1 Apr 2023611.00
1 Mar 2023614.33
1 Feb 2023637.67
1 Jan 2023669.00
1 Dec 2022681.67
1 Nov 2022703.67
1 Oct 2022699.67
1 Sep 2022680.67
1 Aug 2022617.33
1 Jul 2022578.67
1 Jun 2022563.33
1 May 2022577.00
1 Apr 2022560.67
1 Mar 2022559.33
1 Feb 2022557.00
1 Jan 2022619.33
1 Dec 2021659.33
1 Nov 2021675.33
1 Oct 2021639.67
1 Sep 2021611.67
1 Aug 2021585.33
1 Jul 2021575.67
1 Jun 2021543.67
1 May 2021547.67
1 Apr 2021542.67
Download

Download data

Select format
About

Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change. Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months. Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.

Testing

Rolling monthly average percent of K. pneumoniae bacteraemia tested for resistance to carbapenems. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including month of 1 Apr 2026

ChartThere is only 1 plot on this chart. The horizontal X-axis is labelled 'date'. Whilst the vertical Y-axis is labelled 'metric'. This is a dark blue solid line plot. This plot shows data for K-pneumoniae. Specifically the metric 'k-pneumoniae_testing_bacteraemiaPercentTestedRollingMonth' for the England area, along with the age banding of 'all' for the gender group of all. This plot shows data from 01 April 2021 to 01 April 2026. It fell from 97.83 on 01 April 2021 to 97.38 on 01 February 2022. It rose from 97.73 on 01 March 2022 to 97.99 on 01 December 2022. It fell from 97.95 on 01 January 2023 to 95.79 on 01 October 2023. It rose from 96.21 on 01 November 2023 to 96.75 on 01 August 2024. It fell from 96.65 on 01 September 2024 to 96.64 on 01 June 2025. And finally. It fell from 96.99 on 01 July 2025 to 96.47 on 01 April 2026. There is no reporting delay period being tracked for the data on this chart. - Refer to tabular data.
Tabular data

Testing data for rolling monthly average percent of K. pneumoniae bacteraemia tested for resistance to carbapenems. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including 1 April 2026

Month % tested
1 Apr 202696.47
1 Mar 202696.56
1 Feb 202696.44
1 Jan 202696.43
1 Dec 202596.52
1 Nov 202596.63
1 Oct 202597.32
1 Sep 202597.42
1 Aug 202597.14
1 Jul 202596.99
1 Jun 202596.64
1 May 202596.39
1 Apr 202595.99
1 Mar 202596.51
1 Feb 202596.61
1 Jan 202597.10
1 Dec 202496.92
1 Nov 202497.06
1 Oct 202496.91
1 Sep 202496.65
1 Aug 202496.75
1 Jul 202496.94
1 Jun 202497.09
1 May 202496.83
1 Apr 202496.45
1 Mar 202496.14
1 Feb 202496.28
1 Jan 202496.71
1 Dec 202396.76
1 Nov 202396.21
1 Oct 202395.79
1 Sep 202395.88
1 Aug 202396.00
1 Jul 202396.21
1 Jun 202396.63
1 May 202396.90
1 Apr 202397.76
1 Mar 202397.77
1 Feb 202398.00
1 Jan 202397.95
1 Dec 202297.99
1 Nov 202297.91
1 Oct 202297.49
1 Sep 202297.00
1 Aug 202297.17
1 Jul 202297.31
1 Jun 202297.91
1 May 202297.80
1 Apr 202298.25
1 Mar 202297.73
1 Feb 202297.38
1 Jan 202296.72
1 Dec 202196.91
1 Nov 202197.12
1 Oct 202196.67
1 Sep 202196.37
1 Aug 202196.53
1 Jul 202197.29
1 Jun 202197.84
1 May 202197.68
1 Apr 202197.83
Download

Download data

Select format
About

Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change. Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months. Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.

Resistance

Rolling monthly average percent of K. pneumoniae bacteraemia resistant to carbapenems. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including month of 1 Apr 2026

ChartThere is only 1 plot on this chart. The horizontal X-axis is labelled 'date'. Whilst the vertical Y-axis is labelled 'metric'. This is a dark blue solid line plot. This plot shows data for K-pneumoniae. Specifically the metric 'k-pneumoniae_testing_bacteraemiaPercentResistantRollingMonth' for the England area, along with the age banding of 'all' for the gender group of all. This plot shows data from 01 April 2021 to 01 April 2026. It fell from 1.17 on 01 April 2021 to 1.14 on 01 February 2022. It rose from 1.01 on 01 March 2022 to 1.52 on 01 December 2022. It rose from 1.59 on 01 January 2023 to 1.76 on 01 October 2023. It fell from 1.57 on 01 November 2023 to 1.46 on 01 August 2024. It fell from 1.69 on 01 September 2024 to 1.11 on 01 June 2025. And finally. It fell from 1.34 on 01 July 2025 to 1.17 on 01 April 2026. There is no reporting delay period being tracked for the data on this chart. - Refer to tabular data.
Tabular data

Resistance data for rolling monthly average percent of K. pneumoniae bacteraemia resistant to carbapenems. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including 1 April 2026

Month % resistant
1 Apr 20261.17
1 Mar 20261.49
1 Feb 20261.49
1 Jan 20261.52
1 Dec 20251.44
1 Nov 20251.51
1 Oct 20251.61
1 Sep 20251.69
1 Aug 20251.51
1 Jul 20251.34
1 Jun 20251.11
1 May 20251.53
1 Apr 20251.78
1 Mar 20251.67
1 Feb 20251.30
1 Jan 20251.26
1 Dec 20241.65
1 Nov 20241.89
1 Oct 20241.84
1 Sep 20241.69
1 Aug 20241.46
1 Jul 20241.69
1 Jun 20241.43
1 May 20241.42
1 Apr 20241.52
1 Mar 20241.68
1 Feb 20241.68
1 Jan 20241.37
1 Dec 20231.47
1 Nov 20231.57
1 Oct 20231.76
1 Sep 20231.66
1 Aug 20231.48
1 Jul 20231.22
1 Jun 20231.36
1 May 20231.49
1 Apr 20231.64
1 Mar 20231.68
1 Feb 20231.67
1 Jan 20231.59
1 Dec 20221.52
1 Nov 20221.85
1 Oct 20221.72
1 Sep 20221.76
1 Aug 20221.62
1 Jul 20221.79
1 Jun 20221.72
1 May 20221.33
1 Apr 20221.01
1 Mar 20221.01
1 Feb 20221.14
1 Jan 20221.72
1 Dec 20211.67
1 Nov 20211.48
1 Oct 20210.99
1 Sep 20210.76
1 Aug 20210.74
1 Jul 20210.75
1 Jun 20210.80
1 May 20210.97
1 Apr 20211.17
Download

Download data

Select format
About

Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change. Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months. Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.

Ciprofloxacin

Testing

Rolling monthly average number of K. pneumoniae bacteraemia tested for resistance to ciprofloxacin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including month of 1 Apr 2026

ChartThere is only 1 plot on this chart. The horizontal X-axis is labelled 'date'. Whilst the vertical Y-axis is labelled 'metric'. This is a dark blue solid bar plot. This plot shows data for K-pneumoniae. Specifically the metric 'k-pneumoniae_testing_bacteraemiaNumberTestedRollingMonth' for the England area, along with the age banding of 'all' for the gender group of all. This plot shows data from 01 April 2021 to 01 April 2026. It rose from 532.33 on 01 April 2021 to 542.67 on 01 February 2022. It rose from 545.0 on 01 March 2022 to 650.67 on 01 December 2022. It rose from 637.67 on 01 January 2023 to 745.67 on 01 October 2023. It fell from 732.33 on 01 November 2023 to 729.0 on 01 August 2024. It fell from 757.67 on 01 September 2024 to 665.0 on 01 June 2025. And finally. It fell from 720.33 on 01 July 2025 to 668.33 on 01 April 2026. There is no reporting delay period being tracked for the data on this chart. - Refer to tabular data.
Tabular data

Testing data for rolling monthly average number of K. pneumoniae bacteraemia tested for resistance to ciprofloxacin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including 1 April 2026

Month Number tested
1 Apr 2026668.33
1 Mar 2026682.67
1 Feb 2026697.00
1 Jan 2026743.67
1 Dec 2025772.33
1 Nov 2025797.33
1 Oct 2025809.00
1 Sep 2025806.33
1 Aug 2025758.33
1 Jul 2025720.33
1 Jun 2025665.00
1 May 2025668.00
1 Apr 2025646.00
1 Mar 2025670.33
1 Feb 2025687.67
1 Jan 2025707.33
1 Dec 2024727.33
1 Nov 2024731.33
1 Oct 2024764.00
1 Sep 2024757.67
1 Aug 2024729.00
1 Jul 2024682.33
1 Jun 2024657.33
1 May 2024661.33
1 Apr 2024646.67
1 Mar 2024638.67
1 Feb 2024639.33
1 Jan 2024664.67
1 Dec 2023708.33
1 Nov 2023732.33
1 Oct 2023745.67
1 Sep 2023715.33
1 Aug 2023688.33
1 Jul 2023654.33
1 Jun 2023632.33
1 May 2023600.00
1 Apr 2023584.33
1 Mar 2023585.00
1 Feb 2023605.67
1 Jan 2023637.67
1 Dec 2022650.67
1 Nov 2022676.67
1 Oct 2022672.67
1 Sep 2022661.67
1 Aug 2022597.33
1 Jul 2022565.67
1 Jun 2022546.33
1 May 2022561.67
1 Apr 2022544.00
1 Mar 2022545.00
1 Feb 2022542.67
1 Jan 2022598.67
1 Dec 2021636.67
1 Nov 2021654.33
1 Oct 2021626.67
1 Sep 2021601.00
1 Aug 2021572.67
1 Jul 2021558.67
1 Jun 2021525.00
1 May 2021535.00
1 Apr 2021532.33
Download

Download data

Select format
About

Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change. Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months. Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.

Testing

Rolling monthly average percent of K. pneumoniae bacteraemia tested for resistance to ciprofloxacin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including month of 1 Apr 2026

ChartThere is only 1 plot on this chart. The horizontal X-axis is labelled 'date'. Whilst the vertical Y-axis is labelled 'metric'. This is a dark blue solid line plot. This plot shows data for K-pneumoniae. Specifically the metric 'k-pneumoniae_testing_bacteraemiaPercentTestedRollingMonth' for the England area, along with the age banding of 'all' for the gender group of all. This plot shows data from 01 April 2021 to 01 April 2026. It fell from 96.03 on 01 April 2021 to 94.76 on 01 February 2022. It fell from 95.28 on 01 March 2022 to 93.53 on 01 December 2022. It fell from 93.27 on 01 January 2023 to 92.2 on 01 October 2023. It fell from 92.42 on 01 November 2023 to 91.12 on 01 August 2024. It fell from 90.66 on 01 September 2024 to 89.26 on 01 June 2025. And finally. It fell from 90.34 on 01 July 2025 to 87.32 on 01 April 2026. There is no reporting delay period being tracked for the data on this chart. - Refer to tabular data.
Tabular data

Testing data for rolling monthly average percent of K. pneumoniae bacteraemia tested for resistance to ciprofloxacin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including 1 April 2026

Month % tested
1 Apr 202687.32
1 Mar 202686.88
1 Feb 202688.56
1 Jan 202688.45
1 Dec 202589.56
1 Nov 202589.55
1 Oct 202590.49
1 Sep 202590.36
1 Aug 202590.45
1 Jul 202590.34
1 Jun 202589.26
1 May 202589.42
1 Apr 202589.35
1 Mar 202589.93
1 Feb 202589.57
1 Jan 202589.27
1 Dec 202489.64
1 Nov 202489.58
1 Oct 202490.74
1 Sep 202490.66
1 Aug 202491.12
1 Jul 202490.69
1 Jun 202491.12
1 May 202491.05
1 Apr 202491.76
1 Mar 202491.27
1 Feb 202491.42
1 Jan 202490.96
1 Dec 202391.83
1 Nov 202392.42
1 Oct 202392.20
1 Sep 202392.14
1 Aug 202391.73
1 Jul 202391.85
1 Jun 202392.53
1 May 202392.88
1 Apr 202393.44
1 Mar 202393.15
1 Feb 202393.08
1 Jan 202393.27
1 Dec 202293.53
1 Nov 202294.15
1 Oct 202293.72
1 Sep 202294.29
1 Aug 202294.02
1 Jul 202295.12
1 Jun 202294.96
1 May 202295.08
1 Apr 202295.44
1 Mar 202295.28
1 Feb 202294.76
1 Jan 202293.44
1 Dec 202193.53
1 Nov 202194.10
1 Oct 202194.70
1 Sep 202194.79
1 Aug 202194.39
1 Jul 202194.42
1 Jun 202194.59
1 May 202195.54
1 Apr 202196.03
Download

Download data

Select format
About

Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change. Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months. Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.

Resistance

Rolling monthly average percent of K. pneumoniae bacteraemia resistant to ciprofloxacin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including month of 1 Apr 2026

ChartThere is only 1 plot on this chart. The horizontal X-axis is labelled 'date'. Whilst the vertical Y-axis is labelled 'metric'. This is a dark blue solid line plot. This plot shows data for K-pneumoniae. Specifically the metric 'k-pneumoniae_testing_bacteraemiaPercentResistantRollingMonth' for the England area, along with the age banding of 'all' for the gender group of all. This plot shows data from 01 April 2021 to 01 April 2026. It rose from 14.84 on 01 April 2021 to 17.14 on 01 February 2022. It fell from 17.61 on 01 March 2022 to 17.47 on 01 December 2022. It rose from 17.88 on 01 January 2023 to 18.37 on 01 October 2023. It fell from 19.3 on 01 November 2023 to 18.93 on 01 August 2024. It fell from 19.31 on 01 September 2024 to 17.94 on 01 June 2025. And finally. It fell from 18.6 on 01 July 2025 to 17.76 on 01 April 2026. There is no reporting delay period being tracked for the data on this chart. - Refer to tabular data.
Tabular data

Resistance data for rolling monthly average percent of K. pneumoniae bacteraemia resistant to ciprofloxacin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including 1 April 2026

Month % resistant
1 Apr 202617.76
1 Mar 202618.31
1 Feb 202618.22
1 Jan 202617.17
1 Dec 202518.39
1 Nov 202517.64
1 Oct 202518.50
1 Sep 202517.90
1 Aug 202519.43
1 Jul 202518.60
1 Jun 202517.94
1 May 202516.92
1 Apr 202517.54
1 Mar 202517.65
1 Feb 202518.61
1 Jan 202519.13
1 Dec 202420.12
1 Nov 202420.28
1 Oct 202420.11
1 Sep 202419.31
1 Aug 202418.93
1 Jul 202418.95
1 Jun 202418.51
1 May 202418.65
1 Apr 202417.58
1 Mar 202417.64
1 Feb 202417.41
1 Jan 202418.20
1 Dec 202318.54
1 Nov 202319.30
1 Oct 202318.37
1 Sep 202318.08
1 Aug 202317.14
1 Jul 202318.95
1 Jun 202319.40
1 May 202319.39
1 Apr 202318.14
1 Mar 202317.89
1 Feb 202317.12
1 Jan 202317.88
1 Dec 202217.47
1 Nov 202217.54
1 Oct 202215.91
1 Sep 202215.67
1 Aug 202215.23
1 Jul 202215.79
1 Jun 202216.78
1 May 202217.69
1 Apr 202218.08
1 Mar 202217.61
1 Feb 202217.14
1 Jan 202217.43
1 Dec 202117.49
1 Nov 202116.96
1 Oct 202116.01
1 Sep 202115.36
1 Aug 202115.25
1 Jul 202115.16
1 Jun 202115.11
1 May 202115.02
1 Apr 202114.84
Download

Download data

Select format
About

Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change. Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months. Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.

Co-amoxiclav

Testing

Rolling monthly average number of K. pneumoniae bacteraemia tested for resistance to co-amoxiclav. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including month of 1 Apr 2026

ChartThere is only 1 plot on this chart. The horizontal X-axis is labelled 'date'. Whilst the vertical Y-axis is labelled 'metric'. This is a dark blue solid bar plot. This plot shows data for K-pneumoniae. Specifically the metric 'k-pneumoniae_testing_bacteraemiaNumberTestedRollingMonth' for the England area, along with the age banding of 'all' for the gender group of all. This plot shows data from 01 April 2021 to 01 April 2026. It rose from 519.33 on 01 April 2021 to 533.0 on 01 February 2022. It rose from 531.33 on 01 March 2022 to 638.67 on 01 December 2022. It rose from 625.33 on 01 January 2023 to 728.67 on 01 October 2023. The date fluctuates between 719.0 on 01 November 2023, ending with the same value on 01 August 2024. It fell from 747.33 on 01 September 2024 to 666.67 on 01 June 2025. And finally. It fell from 708.33 on 01 July 2025 to 656.33 on 01 April 2026. There is no reporting delay period being tracked for the data on this chart. - Refer to tabular data.
Tabular data

Testing data for rolling monthly average number of K. pneumoniae bacteraemia tested for resistance to co-amoxiclav. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including 1 April 2026

Month Number tested
1 Apr 2026656.33
1 Mar 2026674.33
1 Feb 2026679.67
1 Jan 2026730.67
1 Dec 2025757.67
1 Nov 2025779.67
1 Oct 2025787.00
1 Sep 2025786.67
1 Aug 2025747.67
1 Jul 2025708.33
1 Jun 2025666.67
1 May 2025667.00
1 Apr 2025651.33
1 Mar 2025666.33
1 Feb 2025686.67
1 Jan 2025704.33
1 Dec 2024724.33
1 Nov 2024723.67
1 Oct 2024750.67
1 Sep 2024747.33
1 Aug 2024719.00
1 Jul 2024677.33
1 Jun 2024652.33
1 May 2024654.33
1 Apr 2024634.00
1 Mar 2024622.00
1 Feb 2024625.33
1 Jan 2024657.33
1 Dec 2023694.00
1 Nov 2023719.00
1 Oct 2023728.67
1 Sep 2023704.00
1 Aug 2023675.00
1 Jul 2023645.33
1 Jun 2023617.00
1 May 2023585.33
1 Apr 2023560.00
1 Mar 2023568.33
1 Feb 2023591.00
1 Jan 2023625.33
1 Dec 2022638.67
1 Nov 2022652.33
1 Oct 2022655.00
1 Sep 2022638.33
1 Aug 2022589.00
1 Jul 2022556.67
1 Jun 2022541.67
1 May 2022550.33
1 Apr 2022532.00
1 Mar 2022531.33
1 Feb 2022533.00
1 Jan 2022594.00
1 Dec 2021632.33
1 Nov 2021645.67
1 Oct 2021614.33
1 Sep 2021593.00
1 Aug 2021570.67
1 Jul 2021554.33
1 Jun 2021516.00
1 May 2021522.00
1 Apr 2021519.33
Download

Download data

Select format
About

Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change. Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months. Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.

Testing

Rolling monthly average percent of K. pneumoniae bacteraemia tested for resistance to co-amoxiclav. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including month of 1 Apr 2026

ChartThere is only 1 plot on this chart. The horizontal X-axis is labelled 'date'. Whilst the vertical Y-axis is labelled 'metric'. This is a dark blue solid line plot. This plot shows data for K-pneumoniae. Specifically the metric 'k-pneumoniae_testing_bacteraemiaPercentTestedRollingMonth' for the England area, along with the age banding of 'all' for the gender group of all. This plot shows data from 01 April 2021 to 01 April 2026. It fell from 93.68 on 01 April 2021 to 93.18 on 01 February 2022. It fell from 92.83 on 01 March 2022 to 91.8 on 01 December 2022. It fell from 91.51 on 01 January 2023 to 90.1 on 01 October 2023. It fell from 90.78 on 01 November 2023 to 89.88 on 01 August 2024. It fell from 89.46 on 01 September 2024 to 89.4 on 01 June 2025. And finally. It fell from 88.83 on 01 July 2025 to 85.75 on 01 April 2026. There is no reporting delay period being tracked for the data on this chart. - Refer to tabular data.
Tabular data

Testing data for rolling monthly average percent of K. pneumoniae bacteraemia tested for resistance to co-amoxiclav. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including 1 April 2026

Month % tested
1 Apr 202685.75
1 Mar 202685.86
1 Feb 202686.28
1 Jan 202686.90
1 Dec 202587.82
1 Nov 202587.53
1 Oct 202588.03
1 Sep 202588.12
1 Aug 202589.14
1 Jul 202588.83
1 Jun 202589.40
1 May 202589.29
1 Apr 202590.04
1 Mar 202589.40
1 Feb 202589.44
1 Jan 202588.89
1 Dec 202489.27
1 Nov 202488.60
1 Oct 202489.07
1 Sep 202489.46
1 Aug 202489.88
1 Jul 202490.03
1 Jun 202490.43
1 May 202490.08
1 Apr 202490.06
1 Mar 202488.98
1 Feb 202489.41
1 Jan 202490.00
1 Dec 202390.01
1 Nov 202390.78
1 Oct 202390.10
1 Sep 202390.72
1 Aug 202390.00
1 Jul 202390.59
1 Jun 202390.34
1 May 202390.56
1 Apr 202389.60
1 Mar 202390.45
1 Feb 202390.92
1 Jan 202391.51
1 Dec 202291.80
1 Nov 202290.81
1 Oct 202291.35
1 Sep 202291.01
1 Aug 202292.76
1 Jul 202293.60
1 Jun 202294.09
1 May 202293.22
1 Apr 202293.33
1 Mar 202292.83
1 Feb 202293.18
1 Jan 202292.81
1 Dec 202192.94
1 Nov 202192.81
1 Oct 202192.89
1 Sep 202193.53
1 Aug 202194.06
1 Jul 202193.74
1 Jun 202192.97
1 May 202193.21
1 Apr 202193.68
Download

Download data

Select format
About

Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change. Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months. Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.

Resistance

Rolling monthly average percent of K. pneumoniae bacteraemia resistant to co-amoxiclav. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including month of 1 Apr 2026

ChartThere is only 1 plot on this chart. The horizontal X-axis is labelled 'date'. Whilst the vertical Y-axis is labelled 'metric'. This is a dark blue solid line plot. This plot shows data for K-pneumoniae. Specifically the metric 'k-pneumoniae_testing_bacteraemiaPercentResistantRollingMonth' for the England area, along with the age banding of 'all' for the gender group of all. This plot shows data from 01 April 2021 to 01 April 2026. It rose from 28.75 on 01 April 2021 to 30.33 on 01 February 2022. It rose from 30.61 on 01 March 2022 to 32.15 on 01 December 2022. It rose from 33.1 on 01 January 2023 to 34.08 on 01 October 2023. It fell from 35.84 on 01 November 2023 to 32.96 on 01 August 2024. It fell from 33.76 on 01 September 2024 to 32.15 on 01 June 2025. And finally. It rose from 32.19 on 01 July 2025 to 33.42 on 01 April 2026. There is no reporting delay period being tracked for the data on this chart. - Refer to tabular data.
Tabular data

Resistance data for rolling monthly average percent of K. pneumoniae bacteraemia resistant to co-amoxiclav. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including 1 April 2026

Month % resistant
1 Apr 202633.42
1 Mar 202634.95
1 Feb 202635.31
1 Jan 202633.71
1 Dec 202533.96
1 Nov 202533.86
1 Oct 202533.50
1 Sep 202532.58
1 Aug 202533.13
1 Jul 202532.19
1 Jun 202532.15
1 May 202531.28
1 Apr 202533.37
1 Mar 202532.82
1 Feb 202532.82
1 Jan 202533.36
1 Dec 202433.50
1 Nov 202435.42
1 Oct 202434.41
1 Sep 202433.76
1 Aug 202432.96
1 Jul 202433.61
1 Jun 202433.47
1 May 202432.91
1 Apr 202431.44
1 Mar 202431.83
1 Feb 202433.05
1 Jan 202434.84
1 Dec 202336.36
1 Nov 202335.84
1 Oct 202334.08
1 Sep 202332.91
1 Aug 202331.60
1 Jul 202332.28
1 Jun 202332.52
1 May 202332.12
1 Apr 202332.56
1 Mar 202333.26
1 Feb 202333.28
1 Jan 202333.10
1 Dec 202232.15
1 Nov 202232.14
1 Oct 202231.45
1 Sep 202230.08
1 Aug 202228.98
1 Jul 202227.07
1 Jun 202227.75
1 May 202229.25
1 Apr 202231.02
1 Mar 202230.61
1 Feb 202230.33
1 Jan 202231.59
1 Dec 202131.89
1 Nov 202130.82
1 Oct 202128.27
1 Sep 202128.33
1 Aug 202129.26
1 Jul 202129.95
1 Jun 202129.01
1 May 202128.03
1 Apr 202128.75
Download

Download data

Select format
About

Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change. Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months. Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.

Gentamicin

Testing

Rolling monthly average number of K. pneumoniae bacteraemia tested for resistance to gentamicin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including month of 1 Apr 2026

ChartThere is only 1 plot on this chart. The horizontal X-axis is labelled 'date'. Whilst the vertical Y-axis is labelled 'metric'. This is a dark blue solid bar plot. This plot shows data for K-pneumoniae. Specifically the metric 'k-pneumoniae_testing_bacteraemiaNumberTestedRollingMonth' for the England area, along with the age banding of 'all' for the gender group of all. This plot shows data from 01 April 2021 to 01 April 2026. It rose from 541.0 on 01 April 2021 to 553.33 on 01 February 2022. It rose from 553.0 on 01 March 2022 to 657.33 on 01 December 2022. It rose from 646.0 on 01 January 2023 to 755.67 on 01 October 2023. It rose from 735.33 on 01 November 2023 to 741.0 on 01 August 2024. It fell from 772.67 on 01 September 2024 to 670.0 on 01 June 2025. And finally. It fell from 721.33 on 01 July 2025 to 683.67 on 01 April 2026. There is no reporting delay period being tracked for the data on this chart. - Refer to tabular data.
Tabular data

Testing data for rolling monthly average number of K. pneumoniae bacteraemia tested for resistance to gentamicin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including 1 April 2026

Month Number tested
1 Apr 2026683.67
1 Mar 2026700.33
1 Feb 2026706.33
1 Jan 2026756.67
1 Dec 2025774.33
1 Nov 2025798.67
1 Oct 2025810.00
1 Sep 2025818.67
1 Aug 2025768.00
1 Jul 2025721.33
1 Jun 2025670.00
1 May 2025675.00
1 Apr 2025659.67
1 Mar 2025681.00
1 Feb 2025700.33
1 Jan 2025720.33
1 Dec 2024738.00
1 Nov 2024748.33
1 Oct 2024779.00
1 Sep 2024772.67
1 Aug 2024741.00
1 Jul 2024697.00
1 Jun 2024672.00
1 May 2024670.00
1 Apr 2024641.33
1 Mar 2024637.33
1 Feb 2024647.33
1 Jan 2024681.33
1 Dec 2023721.00
1 Nov 2023735.33
1 Oct 2023755.67
1 Sep 2023720.33
1 Aug 2023696.67
1 Jul 2023663.00
1 Jun 2023640.67
1 May 2023608.67
1 Apr 2023586.00
1 Mar 2023590.00
1 Feb 2023611.00
1 Jan 2023646.00
1 Dec 2022657.33
1 Nov 2022681.67
1 Oct 2022675.33
1 Sep 2022664.33
1 Aug 2022604.00
1 Jul 2022571.00
1 Jun 2022553.33
1 May 2022568.33
1 Apr 2022553.33
1 Mar 2022553.00
1 Feb 2022553.33
1 Jan 2022614.67
1 Dec 2021654.67
1 Nov 2021672.00
1 Oct 2021637.33
1 Sep 2021609.33
1 Aug 2021578.00
1 Jul 2021566.33
1 Jun 2021535.33
1 May 2021542.67
1 Apr 2021541.00
Download

Download data

Select format
About

Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change. Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months. Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.

Testing

Rolling monthly average percent of K. pneumoniae bacteraemia tested for resistance to gentamicin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including month of 1 Apr 2026

ChartThere is only 1 plot on this chart. The horizontal X-axis is labelled 'date'. Whilst the vertical Y-axis is labelled 'metric'. This is a dark blue solid line plot. This plot shows data for K-pneumoniae. Specifically the metric 'k-pneumoniae_testing_bacteraemiaPercentTestedRollingMonth' for the England area, along with the age banding of 'all' for the gender group of all. This plot shows data from 01 April 2021 to 01 April 2026. It fell from 97.65 on 01 April 2021 to 96.68 on 01 February 2022. It fell from 96.68 on 01 March 2022 to 94.53 on 01 December 2022. It fell from 94.58 on 01 January 2023 to 93.44 on 01 October 2023. It fell from 92.8 on 01 November 2023 to 92.62 on 01 August 2024. It fell from 92.46 on 01 September 2024 to 89.93 on 01 June 2025. And finally. It fell from 90.46 on 01 July 2025 to 89.28 on 01 April 2026. There is no reporting delay period being tracked for the data on this chart. - Refer to tabular data.
Tabular data

Testing data for rolling monthly average percent of K. pneumoniae bacteraemia tested for resistance to gentamicin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including 1 April 2026

Month % tested
1 Apr 202689.28
1 Mar 202689.17
1 Feb 202689.71
1 Jan 202690.00
1 Dec 202589.79
1 Nov 202589.66
1 Oct 202590.60
1 Sep 202591.70
1 Aug 202591.65
1 Jul 202590.46
1 Jun 202589.93
1 May 202590.36
1 Apr 202591.15
1 Mar 202591.41
1 Feb 202591.26
1 Jan 202590.91
1 Dec 202491.00
1 Nov 202491.67
1 Oct 202492.52
1 Sep 202492.46
1 Aug 202492.62
1 Jul 202492.69
1 Jun 202493.20
1 May 202492.29
1 Apr 202491.05
1 Mar 202491.13
1 Feb 202492.56
1 Jan 202493.29
1 Dec 202393.51
1 Nov 202392.80
1 Oct 202393.44
1 Sep 202392.78
1 Aug 202392.80
1 Jul 202393.12
1 Jun 202393.70
1 May 202394.12
1 Apr 202393.76
1 Mar 202393.95
1 Feb 202394.00
1 Jan 202394.58
1 Dec 202294.53
1 Nov 202294.85
1 Oct 202294.14
1 Sep 202294.72
1 Aug 202295.12
1 Jul 202296.13
1 Jun 202296.17
1 May 202296.27
1 Apr 202297.02
1 Mar 202296.68
1 Feb 202296.68
1 Jan 202295.94
1 Dec 202196.18
1 Nov 202196.69
1 Oct 202196.37
1 Sep 202196.06
1 Aug 202195.38
1 Jul 202195.77
1 Jun 202196.40
1 May 202196.79
1 Apr 202197.65
Download

Download data

Select format
About

Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change. Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months. Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.

Resistance

Rolling monthly average percent of K. pneumoniae bacteraemia resistant to gentamicin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including month of 1 Apr 2026

ChartThere is only 1 plot on this chart. The horizontal X-axis is labelled 'date'. Whilst the vertical Y-axis is labelled 'metric'. This is a dark blue solid line plot. This plot shows data for K-pneumoniae. Specifically the metric 'k-pneumoniae_testing_bacteraemiaPercentResistantRollingMonth' for the England area, along with the age banding of 'all' for the gender group of all. This plot shows data from 01 April 2021 to 01 April 2026. It rose from 9.3 on 01 April 2021 to 10.24 on 01 February 2022. It rose from 10.19 on 01 March 2022 to 10.5 on 01 December 2022. It rose from 10.53 on 01 January 2023 to 10.72 on 01 October 2023. It rose from 11.15 on 01 November 2023 to 13.63 on 01 August 2024. It fell from 13.85 on 01 September 2024 to 9.55 on 01 June 2025. And finally. It fell from 11.37 on 01 July 2025 to 10.58 on 01 April 2026. There is no reporting delay period being tracked for the data on this chart. - Refer to tabular data.
Tabular data

Resistance data for rolling monthly average percent of K. pneumoniae bacteraemia resistant to gentamicin. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including 1 April 2026

Month % resistant
1 Apr 202610.58
1 Mar 202610.71
1 Feb 202610.19
1 Jan 20269.96
1 Dec 202510.37
1 Nov 202510.23
1 Oct 202511.23
1 Sep 202511.77
1 Aug 202512.20
1 Jul 202511.37
1 Jun 20259.55
1 May 20259.63
1 Apr 202511.42
1 Mar 202512.43
1 Feb 202512.90
1 Jan 202512.03
1 Dec 202412.33
1 Nov 202412.69
1 Oct 202413.44
1 Sep 202413.85
1 Aug 202413.63
1 Jul 202412.39
1 Jun 202411.76
1 May 202410.95
1 Apr 202410.55
1 Mar 202410.41
1 Feb 202411.64
1 Jan 202411.94
1 Dec 202311.97
1 Nov 202311.15
1 Oct 202310.72
1 Sep 20239.39
1 Aug 20239.33
1 Jul 202310.21
1 Jun 202311.45
1 May 202310.95
1 Apr 202310.47
1 Mar 202310.28
1 Feb 202310.09
1 Jan 202310.53
1 Dec 202210.50
1 Nov 202210.76
1 Oct 20229.92
1 Sep 20229.43
1 Aug 20229.11
1 Jul 20228.35
1 Jun 20228.92
1 May 20229.15
1 Apr 202210.42
1 Mar 202210.19
1 Feb 202210.24
1 Jan 202210.52
1 Dec 202110.49
1 Nov 202110.52
1 Oct 20219.57
1 Sep 20219.03
1 Aug 20218.42
1 Jul 20218.24
1 Jun 20218.28
1 May 20218.66
1 Apr 20219.30
Download

Download data

Select format
About

Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change. Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months. Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.

Piperacillin with tazobactam

Testing

Rolling monthly average number of K. pneumoniae bacteraemia tested for resistance to piperacillin with tazobactam. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including month of 1 Apr 2026

ChartThere is only 1 plot on this chart. The horizontal X-axis is labelled 'date'. Whilst the vertical Y-axis is labelled 'metric'. This is a dark blue solid bar plot. This plot shows data for K-pneumoniae. Specifically the metric 'k-pneumoniae_testing_bacteraemiaNumberTestedRollingMonth' for the England area, along with the age banding of 'all' for the gender group of all. This plot shows data from 01 April 2021 to 01 April 2026. It rose from 512.0 on 01 April 2021 to 519.33 on 01 February 2022. It rose from 518.33 on 01 March 2022 to 627.0 on 01 December 2022. It rose from 615.67 on 01 January 2023 to 712.33 on 01 October 2023. It fell from 705.67 on 01 November 2023 to 705.0 on 01 August 2024. It fell from 728.67 on 01 September 2024 to 674.33 on 01 June 2025. And finally. It fell from 720.33 on 01 July 2025 to 675.33 on 01 April 2026. There is no reporting delay period being tracked for the data on this chart. - Refer to tabular data.
Tabular data

Testing data for rolling monthly average number of K. pneumoniae bacteraemia tested for resistance to piperacillin with tazobactam. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including 1 April 2026

Month Number tested
1 Apr 2026675.33
1 Mar 2026694.67
1 Feb 2026701.67
1 Jan 2026750.33
1 Dec 2025772.33
1 Nov 2025796.00
1 Oct 2025807.00
1 Sep 2025804.00
1 Aug 2025763.33
1 Jul 2025720.33
1 Jun 2025674.33
1 May 2025668.00
1 Apr 2025654.33
1 Mar 2025673.00
1 Feb 2025701.00
1 Jan 2025722.00
1 Dec 2024737.67
1 Nov 2024727.00
1 Oct 2024741.67
1 Sep 2024728.67
1 Aug 2024705.00
1 Jul 2024665.33
1 Jun 2024640.67
1 May 2024642.67
1 Apr 2024617.67
1 Mar 2024609.00
1 Feb 2024606.33
1 Jan 2024640.33
1 Dec 2023684.33
1 Nov 2023705.67
1 Oct 2023712.33
1 Sep 2023683.33
1 Aug 2023661.67
1 Jul 2023634.67
1 Jun 2023607.67
1 May 2023573.67
1 Apr 2023557.67
1 Mar 2023562.33
1 Feb 2023586.67
1 Jan 2023615.67
1 Dec 2022627.00
1 Nov 2022647.33
1 Oct 2022643.33
1 Sep 2022628.67
1 Aug 2022576.00
1 Jul 2022543.33
1 Jun 2022525.67
1 May 2022530.67
1 Apr 2022512.67
1 Mar 2022518.33
1 Feb 2022519.33
1 Jan 2022585.33
1 Dec 2021619.33
1 Nov 2021639.00
1 Oct 2021601.67
1 Sep 2021576.67
1 Aug 2021551.00
1 Jul 2021542.00
1 Jun 2021514.33
1 May 2021516.00
1 Apr 2021512.00
Download

Download data

Select format
About

Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change. Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months. Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.

Testing

Rolling monthly average percent of K. pneumoniae bacteraemia tested for resistance to piperacillin with tazobactam. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including month of 1 Apr 2026

ChartThere is only 1 plot on this chart. The horizontal X-axis is labelled 'date'. Whilst the vertical Y-axis is labelled 'metric'. This is a dark blue solid line plot. This plot shows data for K-pneumoniae. Specifically the metric 'k-pneumoniae_testing_bacteraemiaPercentTestedRollingMonth' for the England area, along with the age banding of 'all' for the gender group of all. This plot shows data from 01 April 2021 to 01 April 2026. It fell from 92.42 on 01 April 2021 to 90.73 on 01 February 2022. It fell from 90.56 on 01 March 2022 to 90.22 on 01 December 2022. It fell from 90.04 on 01 January 2023 to 88.12 on 01 October 2023. It fell from 89.02 on 01 November 2023 to 88.12 on 01 August 2024. It rose from 87.19 on 01 September 2024 to 90.47 on 01 June 2025. And finally. It fell from 90.34 on 01 July 2025 to 88.24 on 01 April 2026. There is no reporting delay period being tracked for the data on this chart. - Refer to tabular data.
Tabular data

Testing data for rolling monthly average percent of K. pneumoniae bacteraemia tested for resistance to piperacillin with tazobactam. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including 1 April 2026

Month % tested
1 Apr 202688.24
1 Mar 202688.41
1 Feb 202689.07
1 Jan 202689.29
1 Dec 202589.56
1 Nov 202589.44
1 Oct 202590.27
1 Sep 202590.13
1 Aug 202591.05
1 Jul 202590.34
1 Jun 202590.47
1 May 202589.42
1 Apr 202590.46
1 Mar 202590.34
1 Feb 202591.40
1 Jan 202591.16
1 Dec 202490.88
1 Nov 202489.09
1 Oct 202488.00
1 Sep 202487.19
1 Aug 202488.12
1 Jul 202488.43
1 Jun 202488.77
1 May 202488.43
1 Apr 202487.64
1 Mar 202487.12
1 Feb 202486.70
1 Jan 202487.67
1 Dec 202388.72
1 Nov 202389.02
1 Oct 202388.12
1 Sep 202388.02
1 Aug 202388.13
1 Jul 202389.04
1 Jun 202388.87
1 May 202388.70
1 Apr 202389.12
1 Mar 202389.49
1 Feb 202390.15
1 Jan 202390.04
1 Dec 202290.22
1 Nov 202290.11
1 Oct 202289.68
1 Sep 202289.59
1 Aug 202290.71
1 Jul 202291.41
1 Jun 202291.30
1 May 202289.83
1 Apr 202289.82
1 Mar 202290.56
1 Feb 202290.73
1 Jan 202291.41
1 Dec 202191.03
1 Nov 202191.94
1 Oct 202190.92
1 Sep 202190.85
1 Aug 202190.92
1 Jul 202191.71
1 Jun 202192.61
1 May 202192.14
1 Apr 202192.42
Download

Download data

Select format
About

Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change. Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months. Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.

Resistance

Rolling monthly average percent of K. pneumoniae bacteraemia resistant to piperacillin with tazobactam. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including month of 1 Apr 2026

ChartThere is only 1 plot on this chart. The horizontal X-axis is labelled 'date'. Whilst the vertical Y-axis is labelled 'metric'. This is a dark blue solid line plot. This plot shows data for K-pneumoniae. Specifically the metric 'k-pneumoniae_testing_bacteraemiaPercentResistantRollingMonth' for the England area, along with the age banding of 'all' for the gender group of all. This plot shows data from 01 April 2021 to 01 April 2026. It rose from 18.1 on 01 April 2021 to 18.49 on 01 February 2022. It rose from 19.16 on 01 March 2022 to 22.06 on 01 December 2022. It rose from 23.71 on 01 January 2023 to 24.61 on 01 October 2023. It fell from 26.36 on 01 November 2023 to 22.65 on 01 August 2024. It rose from 23.15 on 01 September 2024 to 23.23 on 01 June 2025. And finally. It fell from 22.67 on 01 July 2025 to 20.83 on 01 April 2026. There is no reporting delay period being tracked for the data on this chart. - Refer to tabular data.
Tabular data

Resistance data for rolling monthly average percent of K. pneumoniae bacteraemia resistant to piperacillin with tazobactam. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including 1 April 2026

Month % resistant
1 Apr 202620.83
1 Mar 202622.02
1 Feb 202622.38
1 Jan 202623.01
1 Dec 202523.87
1 Nov 202523.66
1 Oct 202523.17
1 Sep 202522.06
1 Aug 202523.14
1 Jul 202522.67
1 Jun 202523.23
1 May 202522.65
1 Apr 202524.61
1 Mar 202523.97
1 Feb 202524.44
1 Jan 202523.59
1 Dec 202424.54
1 Nov 202425.03
1 Oct 202424.58
1 Sep 202423.15
1 Aug 202422.65
1 Jul 202423.25
1 Jun 202423.78
1 May 202423.76
1 Apr 202423.37
1 Mar 202423.54
1 Feb 202423.09
1 Jan 202424.73
1 Dec 202325.43
1 Nov 202326.36
1 Oct 202324.61
1 Sep 202324.39
1 Aug 202323.22
1 Jul 202322.79
1 Jun 202322.76
1 May 202322.37
1 Apr 202323.43
1 Mar 202323.59
1 Feb 202323.81
1 Jan 202323.71
1 Dec 202222.06
1 Nov 202221.27
1 Oct 202220.00
1 Sep 202219.78
1 Aug 202219.62
1 Jul 202218.34
1 Jun 202219.02
1 May 202219.91
1 Apr 202220.74
1 Mar 202219.16
1 Feb 202218.49
1 Jan 202219.08
1 Dec 202119.81
1 Nov 202119.61
1 Oct 202117.89
1 Sep 202117.92
1 Aug 202117.60
1 Jul 202119.31
1 Jun 202118.73
1 May 202118.02
1 Apr 202118.10
Download

Download data

Select format
About

Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change. Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months. Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.

Third-generation cephalosporins

Testing

Rolling monthly average number of K. pneumoniae bacteraemia tested for resistance to third-generation cephalosporins. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including month of 1 Apr 2026

ChartThere is only 1 plot on this chart. The horizontal X-axis is labelled 'date'. Whilst the vertical Y-axis is labelled 'metric'. This is a dark blue solid bar plot. This plot shows data for K-pneumoniae. Specifically the metric 'k-pneumoniae_testing_bacteraemiaNumberTestedRollingMonth' for the England area, along with the age banding of 'all' for the gender group of all. This plot shows data from 01 April 2021 to 01 April 2026. It rose from 542.67 on 01 April 2021 to 557.67 on 01 February 2022. It rose from 560.33 on 01 March 2022 to 682.0 on 01 December 2022. It rose from 667.33 on 01 January 2023 to 776.33 on 01 October 2023. It rose from 762.67 on 01 November 2023 to 775.33 on 01 August 2024. It fell from 810.33 on 01 September 2024 to 719.67 on 01 June 2025. And finally. It fell from 773.33 on 01 July 2025 to 732.67 on 01 April 2026. There is no reporting delay period being tracked for the data on this chart. - Refer to tabular data.
Tabular data

Testing data for rolling monthly average number of K. pneumoniae bacteraemia tested for resistance to third-generation cephalosporins. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including 1 April 2026

Month Number tested
1 Apr 2026732.67
1 Mar 2026752.33
1 Feb 2026754.00
1 Jan 2026802.67
1 Dec 2025825.00
1 Nov 2025855.67
1 Oct 2025864.00
1 Sep 2025865.00
1 Aug 2025811.33
1 Jul 2025773.33
1 Jun 2025719.67
1 May 2025721.33
1 Apr 2025694.33
1 Mar 2025718.67
1 Feb 2025737.67
1 Jan 2025762.00
1 Dec 2024780.00
1 Nov 2024788.33
1 Oct 2024817.33
1 Sep 2024810.33
1 Aug 2024775.33
1 Jul 2024725.33
1 Jun 2024694.00
1 May 2024700.00
1 Apr 2024681.00
1 Mar 2024674.33
1 Feb 2024673.33
1 Jan 2024702.33
1 Dec 2023744.00
1 Nov 2023762.67
1 Oct 2023776.33
1 Sep 2023746.67
1 Aug 2023722.00
1 Jul 2023688.00
1 Jun 2023660.33
1 May 2023626.67
1 Apr 2023608.00
1 Mar 2023609.67
1 Feb 2023633.00
1 Jan 2023667.33
1 Dec 2022682.00
1 Nov 2022705.00
1 Oct 2022700.00
1 Sep 2022680.67
1 Aug 2022616.67
1 Jul 2022576.00
1 Jun 2022561.33
1 May 2022576.00
1 Apr 2022562.00
1 Mar 2022560.33
1 Feb 2022557.67
1 Jan 2022621.33
1 Dec 2021662.00
1 Nov 2021676.33
1 Oct 2021640.33
1 Sep 2021613.67
1 Aug 2021588.67
1 Jul 2021575.33
1 Jun 2021541.67
1 May 2021546.67
1 Apr 2021542.67
Download

Download data

Select format
About

Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change. Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months. Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.

Testing

Rolling monthly average percent of K. pneumoniae bacteraemia tested for resistance to third-generation cephalosporins. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including month of 1 Apr 2026

ChartThere is only 1 plot on this chart. The horizontal X-axis is labelled 'date'. Whilst the vertical Y-axis is labelled 'metric'. This is a dark blue solid line plot. This plot shows data for K-pneumoniae. Specifically the metric 'k-pneumoniae_testing_bacteraemiaPercentTestedRollingMonth' for the England area, along with the age banding of 'all' for the gender group of all. This plot shows data from 01 April 2021 to 01 April 2026. It fell from 97.83 on 01 April 2021 to 97.38 on 01 February 2022. It rose from 97.9 on 01 March 2022 to 98.13 on 01 December 2022. It fell from 97.66 on 01 January 2023 to 96.04 on 01 October 2023. It rose from 96.21 on 01 November 2023 to 96.88 on 01 August 2024. It fell from 97.01 on 01 September 2024 to 96.51 on 01 June 2025. And finally. It fell from 96.99 on 01 July 2025 to 95.69 on 01 April 2026. There is no reporting delay period being tracked for the data on this chart. - Refer to tabular data.
Tabular data

Testing data for rolling monthly average percent of K. pneumoniae bacteraemia tested for resistance to third-generation cephalosporins. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including 1 April 2026

Month % tested
1 Apr 202695.69
1 Mar 202695.80
1 Feb 202695.81
1 Jan 202695.48
1 Dec 202595.71
1 Nov 202596.07
1 Oct 202596.64
1 Sep 202596.97
1 Aug 202596.78
1 Jul 202596.99
1 Jun 202596.51
1 May 202596.52
1 Apr 202595.99
1 Mar 202596.38
1 Feb 202596.09
1 Jan 202596.21
1 Dec 202496.18
1 Nov 202496.57
1 Oct 202497.03
1 Sep 202497.01
1 Aug 202496.88
1 Jul 202496.41
1 Jun 202496.26
1 May 202496.42
1 Apr 202496.73
1 Mar 202496.42
1 Feb 202496.28
1 Jan 202496.16
1 Dec 202396.50
1 Nov 202396.21
1 Oct 202396.04
1 Sep 202396.13
1 Aug 202396.27
1 Jul 202396.63
1 Jun 202396.63
1 May 202396.90
1 Apr 202397.28
1 Mar 202396.97
1 Feb 202397.38
1 Jan 202397.66
1 Dec 202298.13
1 Nov 202298.19
1 Oct 202297.63
1 Sep 202297.00
1 Aug 202297.01
1 Jul 202296.97
1 Jun 202297.57
1 May 202297.63
1 Apr 202298.60
1 Mar 202297.90
1 Feb 202297.38
1 Jan 202297.03
1 Dec 202197.35
1 Nov 202197.27
1 Oct 202196.82
1 Sep 202196.69
1 Aug 202197.03
1 Jul 202197.29
1 Jun 202197.48
1 May 202197.50
1 Apr 202197.83
Download

Download data

Select format
About

Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change. Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months. Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.

Resistance

Rolling monthly average percent of K. pneumoniae bacteraemia resistant to third-generation cephalosporins. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including month of 1 Apr 2026

ChartThere is only 1 plot on this chart. The horizontal X-axis is labelled 'date'. Whilst the vertical Y-axis is labelled 'metric'. This is a dark blue solid line plot. This plot shows data for K-pneumoniae. Specifically the metric 'k-pneumoniae_testing_bacteraemiaPercentResistantRollingMonth' for the England area, along with the age banding of 'all' for the gender group of all. This plot shows data from 01 April 2021 to 01 April 2026. It rose from 16.03 on 01 April 2021 to 16.8 on 01 February 2022. It rose from 17.37 on 01 March 2022 to 19.65 on 01 December 2022. It fell from 19.48 on 01 January 2023 to 19.06 on 01 October 2023. It rose from 20.06 on 01 November 2023 to 20.55 on 01 August 2024. It fell from 21.51 on 01 September 2024 to 17.55 on 01 June 2025. And finally. It rose from 18.41 on 01 July 2025 to 18.93 on 01 April 2026. There is no reporting delay period being tracked for the data on this chart. - Refer to tabular data.
Tabular data

Resistance data for rolling monthly average percent of K. pneumoniae bacteraemia resistant to third-generation cephalosporins. Monthly figures are shown as the first day of each month. For example, the figures for January 2022 are shown as at "1 Jan 2022".

Up to and including 1 April 2026

Month % resistant
1 Apr 202618.93
1 Mar 202619.32
1 Feb 202618.79
1 Jan 202618.27
1 Dec 202518.38
1 Nov 202518.50
1 Oct 202518.33
1 Sep 202518.23
1 Aug 202518.53
1 Jul 202518.41
1 Jun 202517.55
1 May 202518.30
1 Apr 202519.16
1 Mar 202519.02
1 Feb 202518.98
1 Jan 202519.25
1 Dec 202420.60
1 Nov 202421.31
1 Oct 202422.27
1 Sep 202421.51
1 Aug 202420.55
1 Jul 202419.35
1 Jun 202418.92
1 May 202418.57
1 Apr 202417.33
1 Mar 202416.71
1 Feb 202417.33
1 Jan 202418.46
1 Dec 202319.35
1 Nov 202320.06
1 Oct 202319.06
1 Sep 202318.88
1 Aug 202317.31
1 Jul 202318.80
1 Jun 202319.03
1 May 202319.15
1 Apr 202319.02
1 Mar 202318.75
1 Feb 202319.12
1 Jan 202319.48
1 Dec 202219.65
1 Nov 202219.10
1 Oct 202217.90
1 Sep 202216.70
1 Aug 202216.59
1 Jul 202215.80
1 Jun 202216.69
1 May 202216.72
1 Apr 202217.67
1 Mar 202217.37
1 Feb 202216.80
1 Jan 202217.86
1 Dec 202117.77
1 Nov 202118.14
1 Oct 202115.83
1 Sep 202115.54
1 Aug 202115.40
1 Jul 202115.87
1 Jun 202115.88
1 May 202115.67
1 Apr 202116.03
Download

Download data

Select format
About

Source: AMR module of Second Generation Surveillance System (SGSS). SGSS is a live reporting database, and therefore data is subject to change. Note 1: The chart shows a three-month rolling average, so the data shown for one month is the average across that month and the previous two months. Note 2: Interpreting national antibiotic resistance surveillance trends spanning European Committee on Antimicrobial Susceptibility Testing (EUCAST) clinical breakpoint transition periods requires additional consideration to avoid misinterpretation of data.

Related content

Learn more about UKHSA data dashboard topics